Last reviewed · How we verify
Placebo of DA-2803-R
Placebo of DA-2803-R is a Small molecule drug developed by Dong-A ST Co., Ltd.. It is currently FDA-approved.
A placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.
At a glance
| Generic name | Placebo of DA-2803-R |
|---|---|
| Sponsor | Dong-A ST Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo products are inert formulations designed to match the appearance and administration route of an active drug while containing no therapeutic agent. They are used in randomized controlled trials to establish the true efficacy of an investigational drug by comparing outcomes against a non-treatment control. The placebo effect itself may produce measurable but non-pharmacological improvements in patient-reported outcomes.
Approved indications
Common side effects
Key clinical trials
- Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of DA-2803-R CI brief — competitive landscape report
- Placebo of DA-2803-R updates RSS · CI watch RSS
- Dong-A ST Co., Ltd. portfolio CI
Frequently asked questions about Placebo of DA-2803-R
What is Placebo of DA-2803-R?
How does Placebo of DA-2803-R work?
Who makes Placebo of DA-2803-R?
What development phase is Placebo of DA-2803-R in?
Related
- Manufacturer: Dong-A ST Co., Ltd. — full pipeline
- Compare: Placebo of DA-2803-R vs similar drugs
- Pricing: Placebo of DA-2803-R cost, discount & access